Evidence map›Paper›PMID 38542918›Full record

ArticleMolecules (Basel, Switzerland)2024

Design and Synthesis of Novel Squaraine-Based Fluorescent Probe for Far-Red Detection of Chymotrypsin Enzyme.

Shekhar Gupta, Priyanka Balyan, Sai Kiran Mavileti, Shyam S Pandey, Tamaki Kato

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Fluorescent Albumin-BindingInternational journal of molecular sciences · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shekhar GuptaGraduate School of Life Science and Systems Engineering, Kyushu Institute of Technology, 2-4, Hibikino, Kitakyushu 808-0196, Japan.
Priyanka BalyanGraduate School of Life Science and Systems Engineering, Kyushu Institute of Technology, 2-4, Hibikino, Kitakyushu 808-0196, Japan.
Sai Kiran MaviletiGraduate School of Life Science and Systems Engineering, Kyushu Institute of Technology, 2-4, Hibikino, Kitakyushu 808-0196, Japan.ORCID 0009-0001-4164-158X
Shyam S PandeyGraduate School of Life Science and Systems Engineering, Kyushu Institute of Technology, 2-4, Hibikino, Kitakyushu 808-0196, Japan.ORCID 0000-0001-8102-1003
Tamaki KatoGraduate School of Life Science and Systems Engineering, Kyushu Institute of Technology, 2-4, Hibikino, Kitakyushu 808-0196, Japan.ORCID 0000-0001-9080-8916
Kyushu Institute of Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chymotrypsin, a crucial enzyme in human digestion, catalyzes the breakdown of milk proteins, underscoring its significance in both health diagnostics and dairy quality assurance. Addressing the critical need for rapid, cost-effective detection methods, we introduce a groundbreaking approach utilizing far-red technology and HOMO-Förster resonance energy transfer (FRET). Our novel probe, SQ-122 PC, features a unique molecular design that includes a squaraine dye (SQ), a peptide linker, and SQ moieties synthesized through solid-phase peptide synthesis. Demonstrating a remarkable quenching efficiency of 93.75% in a tailored H

Indexed as

ChymotrypsinCyclobutanesFluorescent DyesPhenolsFluorescence Resonance Energy TransferHumansPeptidesChymotrypsinCyclobutanesFluorescent DyesPeptidesPhenolssquarainechymotrypsin detectiondye–peptide conjugatefar-red squaraine dyefluorescence microscopyfluorescent peptideshomo-FRET

Identifiers

PMID38542918
PMCPMC10975582
OpenAlexW4392811199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.